Cricut Inc (398)

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder. 
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Well yeah this one has the most lies.

3rd attempt: you ok with lies, yes or no?

New York Dolls - Looking for a Kiss

https://youtu.be/GvmvMFXWzc8

https://techcrunch.com/2026/07/10/us-cyber-agency-cisa-had-to-build-its-incident-playbook-during-the-incident-agency-reveals/

According to Krebs, the researcher tried to alert the contractor but didn’t hear back. Only after Krebs contacted CISA did the agency take the repository offli

Hey,

Thanks for the links you sent me. My PC blocked all of the URLs due to malware protection. I'm still in GNIS and the other one. I was up but they have dive bombed quite rapidly. Now, in the RED. Both companies are interesting.

I have an idea AF may turn up in discovery when the dots are lined up and connected. AF may look to be a witness in order to avoid being a defendent.

Non-promotional information until there is a press release is a wise move.

We should have news of next step well before years end. Vivos is already approved by FDA to start the EFS. Mayo Clinic needs to review and sign off on the approved conditions for the IRB and that’s just a formality. EFS could start as early as August. And 30 day patient status report about 45 days a

How is this doing? This was a great runner with a 2 year cup and handle.

You really dont have a clue what you are talking about. Just stop.

What do you think BB? Are there any official OTCMarkets notifications/filings and what's this CCLX price of .50 cents? This looks to good to be true.

Galzus Research,

What if the end game is a friendly or two to the shorts were to bid for control at the lowest price possible before full Flaskworks validation or the value of Direct can be fully factored in by most investors while NWBO is still on the OTC? Just wondering. Best wish

WOW...game changer!!Thanks for sharing

LOL LOL LOL LOL

IOW they didnt offer the money they wanted.

I'm having trouble understanding your reasoning here ....but I'll blame that on the Cabernet I'm drinking :--)

AMRN old timers may remember the polls poster Raf would put up ...thats what we need .

I'll go with your statement " I'm with Stumble and Ernie "
My p